NEW DELHI: The countryfirst indigenous mRNA vaccine candidate developed by Gennova, Pune has received approval of drug regulators to initiate phase 1/2 human clinical trials, the Department of Biotechnology he said on Friday. The new mRNA candidate vaccine, HGCO19, is supported by an initial grant from the Ind-CEPI mission of …
Read More »Gennova, the country’s first mRNA vaccine candidate, gets the go-ahead for human trials: DBT | India News
